References
-
1
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silve, M, Kearne M, Magner M, Isner J M.
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.
Circulation Res.
1999;
85
221-228
-
2
Bolognese L, Cerisamo G, Buonamici P, Santini H, Santoro G M, Antoniacci D, Fazzini P F.
Influence of infarctzone viability on left ventricular remodeling after acute myocardial infarction.
Circulation.
1997;
96
3353-3359
-
3
Christian T F, Schwartz R S, Gibbons R J.
Determinants of infarct size in reperfusion therapy for acute myocardial infarction.
Circulation.
1992;
86
81-90
-
4
Kawamoto A, Gwon H C, Iwaguro H, Yamaguchi J I, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner J M, Asahara T.
Therpeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia.
Circulation.
2001;
103
634-637
-
5
Kelm M, Strauer B E.
Interventionelle Therapie des akuten Myokardinfarktes.
Internist.
2001;
42
686-698
-
6
Kessler P D, Byrne B J.
Myoblast cell grafting into heart muscle: cellular biology and potential applications.
Annu Rev Physiol.
1999;
61
243-282
-
7
Kocher A A, Schuster M D, Szaboks M J, Takuma S, Burkhoff D, Wang J, Homma S, Edwards N M, Itescu S.
Neovascularisation of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function.
Nature.
2001;
7
430-436
-
8
Kögler G, Callejas J, Sorg R V, Fischer J, Migliaccio H R, Wernet P.
The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
Bone Marrow Transplant.
1998;
21
233-241
-
9
Martin B J, Shake J G, Brawn J, Rehmond M, Pittenga M F.
Mesenchymal stem cell (MSC) implantation improves regional function in infarcted swine myocardium (abstr).
Circulation.
2000;
102
3299
-
10
Menasché O, Hagege A A, Scorsin N, Pouzet B, Desnos N, Duboc D, Schwartz K l, Vilquin J T, Marolleau J P.
Myoblast transplantation for heart failure.
Lancet.
2001;
357
279-280
-
11
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson S M, Li B, Pikkel J, Mc K ay R, Nadal-Ginard B, Bodine D M, Leri N, Anversa P.
Bone marrow cells regenerate infarcted myocardium.
Nature.
2001;
410
702-705
-
12
Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T.
Mobilisation of endothelial progenitor cells in patients with acute myocardial infarction.
Circulation.
2001;
103
2776-2779
-
13
Sechtem U.
Imaging myocardial area at rest and final infarct size.
Europ Heart J.
2001;
3
C36-C46
(Suppl C)
-
14
Sussman M.
Cardiovascular biology: hearts and bones.
Nature.
2001;
410
640-641
-
15
Strauer B E, Heidland U F, Heintzen M P, Schwartzkopff B.
Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
J Am Coll Cardiol.
1996;
28
1119-1126
-
16
Tomita S, Li R K, Weisel R D, Mickle D A, Kim E F, Sakai T, Jia F Q.
Autologous tranplantation of bone marrow cells improves damaged heart function.
Circulation.
1999;
100
247-256
-
17
Wang J S, Sham-Tim D, Chedrany E, Eliopoulos N, Selipean J, Chin R CJ.
Marrow stromal cells for cellular cardiomyoblasty: the importance of microenviromment for milieu dependent differentiation (abstr).
Circulation.
2000;
102
3300
Correspondence
Prof. Dr. B E Strauer
Klinik für Kardiologie, Pneumonologie und Angiologie, Heinrich-Heine-Universität Düsseldorf
Moorenstraße 5
40225 Düsseldorf
GERMANY
